EFFECTIVE SHARED CARE AGREEMENT OF LISDEXAMFETAMINE FOR THE TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) IN CHILDREN AND ADOLESCENTSEffective Shared Care Agreement • August 2nd, 2021
Contract Type FiledAugust 2nd, 2021Specialist prescriber responsibilities 1 Discuss the benefits and side effects of treatment with the patient and carer (as appropriate).2 Check for possible drug interactions with lisdexamfetamine and patient’s regular medication. Avoid prescribing interacting drugs.3 Assess likelihood of compliance.4 Ensure patient and carer (as appropriate) are given sufficient information about their treatment.5 Perform all baseline tests as stated on the monitoring requirement.6 Initiate and stabilise treatment with lisdexamfetamine. Stabilisation will usually take 6- 12 weeks.7 Supply medication until care is transferred to GP.8 Ask the GP whether he or she is willing to participate in shared care and explain the intention to share care with patient/carer and obtain consent.9 Monitors appropriately as stated on the monitoring requirement.10 Inform GP of the dose to be prescribed, any changes in dose, when to stop treatment and when to refer the patient back to specialist.11 Physical health monitor
EFFECTIVE SHARED CARE AGREEMENT OF METHYLPHENIDATE FOR THE TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) IN CHILDREN AND ADOLESCENTSEffective Shared Care Agreement • August 2nd, 2021
Contract Type FiledAugust 2nd, 2021Specialist prescriber responsibilities 1 Discuss the benefits and side effects of treatment with the patient and carer (as appropriate).2 Check for possible drug interactions with methylphenidate and patient’s regular medication. Avoid prescribing interacting drugs.3 Assess likelihood of compliance.4 Ensure patient and carer (as appropriate) are given sufficient information about their treatment.5 Perform all baseline tests as stated on the monitoring requirement.6 Initiate and stabilise treatment with methylphenidate. Stabilisation will usually take 6- 12 weeks.7 Supply medication until care is transferred to GP.8 Ask the GP whether he or she is willing to participate in shared care and explain the intention to share care with patient/carer and obtain consent.9 Monitors appropriately as stated on the monitoring requirement.10 Inform GP of the dose to be prescribed, any changes in dose, when to stop treatment and when to refer the patient back to specialist.11 Physical health monitorin